Loading...

Sugi Holdings Co.,Ltd.

7649.TJPX
Healthcare
Medical - Pharmaceuticals
¥3824.00
¥39.00(1.03%)

Sugi Holdings Co.,Ltd. (7649.T) Financial Performance & Income Statement Overview

Analyze Sugi Holdings Co.,Ltd. (7649.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
17.94%
17.94%
Operating Income Growth
16.22%
16.22%
Net Income Growth
16.88%
16.88%
Operating Cash Flow Growth
-5.38%
5.38%
Operating Margin
4.85%
4.85%
Gross Margin
31.33%
31.33%
Net Profit Margin
2.93%
2.93%
ROE
10.53%
10.53%
ROIC
15.25%
15.25%

Sugi Holdings Co.,Ltd. (7649.T) Income Statement & Financial Overview

View the income breakdown for Sugi Holdings Co.,Ltd. 7649.T across both annual and quarterly reports.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$243.40B$220.81B$212.85B$200.96B
Cost of Revenue$163.80B$151.10B$147.11B$140.97B
Gross Profit$79.60B$69.71B$65.74B$59.99B
Gross Profit Ratio$0.33$0.32$0.31$0.30
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$65.79B$61.25B$54.06B$51.38B
Operating Expenses$65.79B$61.25B$54.06B$51.38B
Total Costs & Expenses$229.59B$212.35B$201.17B$192.35B
Interest Income$211.00M$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$5.09B$3.53B$3.88B$3.75B
EBITDA$17.93B$11.99B$15.56B$8.61B
EBITDA Ratio$0.07$0.05$0.07$0.04
Operating Income$13.81B$8.46B$11.68B$8.61B
Operating Income Ratio$0.06$0.04$0.05$0.04
Other Income/Expenses (Net)-$4.17B$388.00M-$1.34B$644.00M
Income Before Tax$9.64B$8.85B$10.34B$9.25B
Income Before Tax Ratio$0.04$0.04$0.05$0.05
Income Tax Expense$3.009B$2.85B$3.40B$3.13B
Net Income$6.63B$6.00B$6.94B$6.12B
Net Income Ratio$0.03$0.03$0.03$0.03
EPS$36.65$33.14$38.33$33.84
Diluted EPS$36.65$33.14$38.33$33.84
Weighted Avg Shares Outstanding$180.97M$180.97M$180.97M$180.96M
Weighted Avg Shares Outstanding (Diluted)$180.97M$180.97M$180.97M$180.96M

Over the last four quarters, Sugi Holdings Co.,Ltd.'s revenue moved from $200.96B in Q1 2024 to $243.40B in Q4 2024. Operating income in Q4 2024 was $13.81B, with a strong operating margin of 6%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Sugi Holdings Co.,Ltd. remained robust at $17.93B, reflecting operational efficiency. Net income rose to $6.63B, with an EPS of $36.65. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;